A generic approach to engineer antibody pH-switches using combinatorial histidine scanning libraries and yeast display

References

• Chaparro-Riggers J, Liang H, DeVay RM, Bai L, Sutton JE, Chen W, Geng T, Lindquist K, Casas MG, Boustany LM, et al. Increasing serum half-life and extending cholesterol lowering in vivo by engineering antibody with pH-sensitive binding to PCSK9. J Biol Chem 2012; 287:11090-7; PMID:22294692; http://dx.doi.org/10.1074/jbc.M111.319764
   PubMed Web of Science ®Google Scholar
• Gera N, Hill AB, White DP, Carbonell RG, Rao BM. Design of pH sensitive binding proteins from the hyperthermophilic Sso7d scaffold. PLoS One 2012; 7:e48928; PMID:23145025; http://dx.doi.org/10.1371/journal.pone.0048928
   PubMed Web of Science ®Google Scholar
• Igawa T, Ishii S, Tachibana T, Maeda A, Higuchi Y, Shimaoka S, Moriyama C, Watanabe T, Takubo R, Doi Y, et al. Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization. Nat Biotechnol 2010; 28:1203-7; PMID:20953198; http://dx.doi.org/10.1038/nbt.1691
   PubMed Web of Science ®Google Scholar
• Sarkar CA, Lowenhaupt K, Horan T, Boone TC, Tidor B, Lauffenburger DA. Rational cytokine design for increased lifetime and enhanced potency using pH-activated "histidine switching.” Nat Biotechnol 2002; 20:908-13; PMID:12161759; http://dx.doi.org/10.1038/nbt725
   PubMed Web of Science ®Google Scholar
• Tsukamoto M, Watanabe H, Ooishi A, Honda S. Engineered protein A ligands, derived from a histidine-scanning library, facilitate the affinity purification of IgG under mild acidic conditions. J Biol Eng 2014; 8:15; PMID:25057290; http://dx.doi.org/10.1186/1754-1611-8-15
   PubMed Web of Science ®Google Scholar
• French AR, Tadaki DK, Niyogi SK, Lauffenburger DA. Intracellular trafficking of epidermal growth factor family ligands is directly influenced by the pH sensitivity of the receptor/ligand interaction. J Biol Chem 1995; 270:4334-40; PMID:7876195; http://dx.doi.org/10.1074/jbc.270.9.4334
   PubMed Web of Science ®Google Scholar
• Kulkarni MV, Tettamanzi MC, Murphy JW, Keeler C, Myszka DG, Chayen NE, Lolis EJ, Hodsdon ME. Two independent histidines, one in human prolactin and one in its receptor, are critical for pH-dependent receptor recognition and activation. J Biol Chem 2010; 285:38524-33; PMID:20889499; http://dx.doi.org/10.1074/jbc.M110.172072
   PubMed Web of Science ®Google Scholar
• Maeda K, Kato Y, Sugiyama Y. pH-dependent receptor/ligand dissociation as a determining factor for intracellular sorting of ligands for epidermal growth factor receptors in rat hepatocytes. J Control Release 2002; 82:71-82; PMID:12106978; http://dx.doi.org/10.1016/S0168-3659(02)00126-8
   PubMed Web of Science ®Google Scholar
• Lauffenburger DA, Fallon EM, Haugh JM. Scratching the (cell) surface: cytokine engineering for improved ligand/receptor trafficking dynamics. Chem Biol 1998; 5:R257-63; PMID:9818145; http://dx.doi.org/10.1016/S1074-5521(98)90110-7
   PubMedGoogle Scholar
• Ebner R, Derynck R. Epidermal growth factor and transforming growth factor-alpha: differential intracellular routing and processing of ligand-receptor complexes. Cell Regul 1991; 2:599-612; PMID:1777504
   PubMedGoogle Scholar
• Waterman H, Sabanai I, Geiger B, Yarden Y. Alternative intracellular routing of ErbB receptors may determine signaling potency. J Biol Chem 1998; 273:13819-27; PMID:9593726; http://dx.doi.org/10.1074/jbc.273.22.13819
   PubMed Web of Science ®Google Scholar
• Cama A, Sierra ML, Kadowaki T, Kadowaki H, Quon MJ, Rudiger HW, Dreyer M, Taylor SI. Two mutant alleles of the insulin receptor gene in a family with a genetic form of insulin resistance: a 10 base pair deletion in exon 1 and a mutation substituting serine for asparagine-462. Hum Genet 1995; 95:174-82; PMID:7860063; http://dx.doi.org/10.1007/BF00209397
   PubMed Web of Science ®Google Scholar
• Fallon EM, Liparoto SF, Lee KJ, Ciardelli TL, Lauffenburger DA. Increased endosomal sorting of ligand to recycling enhances potency of an interleukin-2 analog. J Biol Chem 2000; 275:6790-7; PMID:10702236; http://dx.doi.org/10.1074/jbc.275.10.6790
   PubMed Web of Science ®Google Scholar
• Keeler C, Jablonski EM, Albert YB, Taylor BD, Myszka DG, Clevenger CV, Hodsdon ME. The kinetics of binding human prolactin, but not growth hormone, to the prolactin receptor vary over a physiologic pH range. Biochemistry 2007; 46:2398-410; PMID:17279774; http://dx.doi.org/10.1021/bi061958v
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Chen HC, Guigard E, Kay CM, Ryan RO. Molecular studies of pH-dependent ligand interactions with the low-density lipoprotein receptor. Biochemistry 2008; 47:11647-52; PMID:18847225; http://dx.doi.org/10.1021/bi801117t
   PubMed Web of Science ®Google Scholar
• Roopenian DC, Akilesh S. FcRn: the neonatal Fc receptor comes of age. Nat Rev Immunol 2007; 7:715-25; PMID:17703228; http://dx.doi.org/10.1038/nri2155
   PubMed Web of Science ®Google Scholar
• Simister NE, Mostov KE. An Fc receptor structurally related to MHC class I antigens. Nature 1989; 337:184-7; PMID:2911353; http://dx.doi.org/10.1038/337184a0
   PubMed Web of Science ®Google Scholar
• Tesar DB, Bjorkman PJ. An intracellular traffic jam: Fc receptor-mediated transport of immunoglobulin G. Curr Opin Struct Biol 2010; 20:226-33; PMID:20171874; http://dx.doi.org/10.1016/j.sbi.2010.01.010
   PubMed Web of Science ®Google Scholar
• Igawa T, Mimoto F, Hattori K. pH-dependent antigen-binding antibodies as a novel therapeutic modality. Biochim Biophys Acta 2014; 11:1943-50; http://dx.doi.org/10.1016/j.bbapap.2014.08.003
   Web of Science ®Google Scholar
• Devanaboyina SC, Lynch SM, Ober RJ, Ram S, Kim D, Puig-Canto A, Breen S, Kasturirangan S, Fowler S, Peng L, et al. The effect of pH dependence of antibody-antigen interactions on subcellular trafficking dynamics. MAbs 2013; 5:851-9; PMID:24492341; http://dx.doi.org/10.4161/mabs.26389
   PubMed Web of Science ®Google Scholar
• Tanford C. Protein denaturation. C. Theoretical models for the mechanism of denaturation. Adv Protein Chem 1970; 24:1-95; PMID:4912353; http://dx.doi.org/10.1016/S0065-3233(08)60241-7
   PubMedGoogle Scholar
• Warwicker J. A theoretical study of the acidification of the rhinovirus capsid. FEBS Lett 1989; 257:403-7; PMID:2555222; http://dx.doi.org/10.1016/0014-5793(89)81582-0
   PubMed Web of Science ®Google Scholar
• Warwicker J. Model for the differential stabilities of rhinovirus and poliovirus to mild acidic pH, based on electrostatics calculations. J Mol Biol 1992; 223:247-57; PMID:1309885; http://dx.doi.org/10.1016/0022-2836(92)90729-4
   PubMed Web of Science ®Google Scholar
• Kampmann T, Mueller DS, Mark AE, Young PR, Kobe B. The Role of histidine residues in low-pH-mediated viral membrane fusion. Structure 2006; 14:1481-7; PMID:17027497; http://dx.doi.org/10.1016/j.str.2006.07.011
   PubMed Web of Science ®Google Scholar
• Murtaugh ML, Fanning SW, Sharma TM, Terry AM, Horn JR. A combinatorial histidine scanning library approach to engineer highly pH-dependent protein switches. Protein Sci 2011; 20:1619-31; PMID:21766385; http://dx.doi.org/10.1002/pro.696
   PubMed Web of Science ®Google Scholar
• Ito W, Sakato N, Fujio H, Yutani K, Arata Y, Kurosawa Y. The His-probe method: effects of histidine residues introduced into the complementarity-determining regions of antibodies on antigen-antibody interactions at different pH values. FEBS Lett 1992; 309:85-8; PMID:1511750; http://dx.doi.org/10.1016/0014-5793(92)80745-3
   PubMed Web of Science ®Google Scholar
• Strauch EM, Fleishman SJ, Baker D. Computational design of a pH-sensitive IgG binding protein. Proc Natl Acad Sci USA 2014; 111:675-80; PMID:24381156; http://dx.doi.org/10.1073/pnas.1313605111
   PubMed Web of Science ®Google Scholar
• Spassov VZ, Yan L. pH-selective mutagenesis of protein-protein interfaces: in silico design of therapeutic antibodies with prolonged half-life. Proteins 2013; 81:704-14; PMID:23239118; http://dx.doi.org/10.1002/prot.24230
   PubMed Web of Science ®Google Scholar
• Doerner A, Rhiel L, Zielonka S, Kolmar H. Therapeutic antibody engineering by high efficiency cell screening. FEBS Lett 2014; 588:278-87; PMID:24291259; http://dx.doi.org/10.1016/j.febslet.2013.11.025
   PubMed Web of Science ®Google Scholar
• Traxlmayr MW, Lobner E, Hasenhindl C, Stadlmayr G, Oostenbrink C, Ruker F, Obinger C. Construction of pH-sensitive Her2-binding IgG1-Fc by directed evolution. Biotechnol J 2014; 9:1013-22; PMID:24964247; http://dx.doi.org/10.1002/biot.201300483
   PubMed Web of Science ®Google Scholar
• Tracey D, Klareskog L, Sasso EH, Salfeld JG, Tak PP. Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther 2008; 117:244-79; PMID:18155297; http://dx.doi.org/10.1016/j.pharmthera.2007.10.001
   PubMed Web of Science ®Google Scholar
• den BA, van de Putte L, Rau R, Schattenkirchner M, Van RP, Sander O, Binder C, Fenner H, Bankmann Y, Velagapudi R, et al. A single dose, placebo controlled study of the fully human anti-tumor necrosis factor-alpha antibody adalimumab (D2E7) in patients with rheumatoid arthritis. J.Rheumatol 2002; 29:2288-98; PMID:12415583
   PubMed Web of Science ®Google Scholar
• Arnold FH. Directed evolution: creating biocatalysts for the future. Chem Eng Sci 1996; 51:5091-102; http://dx.doi.org/10.1016/S0009-2509(96)00288-6
   Web of Science ®Google Scholar
• Boder ET, Wittrup KD. Yeast surface display for screening combinatorial polypeptide libraries. Nat Biotechnol 1997; 15:553-7; PMID:9181578; http://dx.doi.org/10.1038/nbt0697-553
   PubMed Web of Science ®Google Scholar
• Kaymakcalan Z, Sakorafas P, Bose S, Scesney S, Xiong L, Hanzatian DK, Salfeld J, Sasso EH. Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor. Clin Immunol 2009; 131:308-16; PMID:19188093; http://dx.doi.org/10.1016/j.clim.2009.01.002
   PubMed Web of Science ®Google Scholar
• Estep P, Reid F, Nauman C, Liu Y, Sun T, Sun J, Xu Y. High throughput solution-based measurement of antibody-antigen affinity and epitope binning. MAbs 2013; 5:270-8; PMID:23575269; http://dx.doi.org/10.4161/mabs.23049
   PubMed Web of Science ®Google Scholar
• Wang W, Lu P, Fang Y, Hamuro L, Pittman T, Carr B, Hochman J, Prueksaritanont T. Monoclonal antibodies with identical Fc sequences can bind to FcRn differentially with pharmacokinetic consequences. Drug Metab Dispos 2011; 39:1469-77; PMID:21610128; http://dx.doi.org/10.1124/dmd.111.039453
   PubMed Web of Science ®Google Scholar
• Martin WL, Bjorkman PJ. Characterization of the 2:1 complex between the class I MHC-related Fc receptor and its Fc ligand in solution. Biochemistry 1999; 38:12639-47; PMID:10504233; http://dx.doi.org/10.1021/bi9913505
   PubMed Web of Science ®Google Scholar
• Pepper LR, Cho YK, Boder ET, Shusta EV. A decade of yeast surface display technology: where are we now? Comb Chem High Throughput Screen 2008; 11:127-34; PMID:18336206; http://dx.doi.org/10.2174/138620708783744516
   PubMed Web of Science ®Google Scholar
• Hu S, Liang S, Guo H, Zhang D, Li H, Wang X, Yang W, Qian W, Hou S, Wang H, et al. Comparison of the inhibition mechanisms of adalimumab and infliximab in treating tumor necrosis factor alpha-associated diseases from a molecular view. J Biol Chem 2013; 288:27059-67; PMID:23943614; http://dx.doi.org/10.1074/jbc.M113.491530
   PubMed Web of Science ®Google Scholar
• Johnson G, Wu TT. Kabat Database and its applications: future directions. Nucleic Acids Res 2001; 29:205-6; PMID:11125092; http://dx.doi.org/10.1093/nar/29.1.205
   PubMed Web of Science ®Google Scholar
• Gurbaxani B, Dostalek M, Gardner I. Are endosomal trafficking parameters better targets for improving mAb pharmacokinetics than FcRn binding affinity? Mol Immunol 2013; 56:660-74; PMID:23917469; http://dx.doi.org/10.1016/j.molimm.2013.05.008
   PubMed Web of Science ®Google Scholar
• Hopkins CR, Trowbridge IS. Internalization and processing of transferrin and the transferrin receptor in human carcinoma A431 cells. J Cell Biol 1983; 97:508-21; PMID:6309862; http://dx.doi.org/10.1083/jcb.97.2.508
   PubMed Web of Science ®Google Scholar
• Ober RJ, Martinez C, Vaccaro C, Zhou J, Ward ES. Visualizing the site and dynamics of IgG salvage by the MHC class I-related receptor, FcRn. J Immunol 2004; 172:2021-9; PMID:14764666; http://dx.doi.org/10.4049/jimmunol.172.4.2021
   PubMed Web of Science ®Google Scholar
• Rakestraw JA, Sazinsky SL, Piatesi A, Antipov E, Wittrup KD. Directed evolution of a secretory leader for the improved expression of heterologous proteins and full-length antibodies in Saccharomyces cerevisiae. Biotechnol Bioeng 2009; 103:1192-201; PMID:19459139; http://dx.doi.org/10.1002/bit.22338
   PubMed Web of Science ®Google Scholar
• Suga M, Hatakeyama T. High-efficiency electroporation by freezing intact yeast cells with addition of calcium. Curr Genet 2003; 43:206-11; PMID:12684838
   PubMed Web of Science ®Google Scholar
• Benatuil L, Perez JM, Belk J, Hsieh CM. An improved yeast transformation method for the generation of very large human antibody libraries. Protein Eng Des Sel 2010; 23:155-9; PMID:20130105; http://dx.doi.org/10.1093/protein/gzq002
   PubMed Web of Science ®Google Scholar
• Bubeck P, Winkler M, Bautsch W. Rapid cloning by homologous recombination in vivo. Nucleic Acids Res 1993; 21:3601-2; PMID:8346047; http://dx.doi.org/10.1093/nar/21.15.3601
   PubMed Web of Science ®Google Scholar
• Lo MC, Aulabaugh A, Jin G, Cowling R, Bard J, Malamas M, Ellestad G. Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery. Anal Biochem 2004; 332:153-9; PMID:15301960; http://dx.doi.org/10.1016/j.ab.2004.04.031
   PubMed Web of Science ®Google Scholar
• Duan Y, Wu C, Chowdhury S, Lee MC, Xiong G, Zhang W, Yang R, Cieplak P, Luo R, Lee T, et al. A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J Comput Chem 2003; 24:1999-2012; PMID:14531054; http://dx.doi.org/10.1002/jcc.10349
   PubMed Web of Science ®Google Scholar
• Krieger E, Darden T, Nabuurs SB, Finkelstein A, Vriend G. Making optimal use of empirical energy functions: force-field parameterization in crystal space. Proteins 2004; 57:678-83; PMID:15390263; http://dx.doi.org/10.1002/prot.20251
   PubMed Web of Science ®Google Scholar